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BerlinHeart EXCOR arterial cannula with bovine pericardiumTonny D. T. Tjan, MD, Andreas Hoffmeier, MD, Hans Heinrich Scheld, MD, and Stefan Klotz, MD,
Mu¨nster, GermanyIn cases of terminal heart failure in neonates, implantation of
an extracorporeal membrane oxygenation (ECMO) device is
often considered as a first choice. Long-term support with
ECMO, however, has several limitations.
Switching from ECMO to a ventricular assist device
(VAD) is therefore a common option for long-term support.1
For neonates, however, only paracorporeal devices are fea-
sible. In contrast to Europe such VAD systems have not
been approved by the US Food and Drug Administration.
In October 2008, the German based company BerlinHeart
(Berlin Heart GmbH, Berlin, Germany) received an uncon-
ditional investigational device exemption for its EXCOR Pe-
diatric VAD system. This system, a paracorporeally placed
pump, is available in pump sizes ranging from 10 to 60
mL in volume. A limitation of this system is that the suture
ring of the inflexible arterial cannulas is relatively large and
rigid. In neonates with a very small ascending aorta, the size
and rigidity lead to difficulties in adjusting and fixing the ar-
terial cannula with the standard technique with a small inci-
sion at the ascending aorta.
Here we describe a technique that uses bovine pericar-
dium to adjust the aortic incision to the large inflexible su-
ture ring for implantation of the EXCOR device in neonates.CLINICAL SUMMARY
We report the case of a 3-month-old infant with anoma-
lous origin of the left coronary artery from the pulmonary ar-
tery. Operative correction with transfer of the anomalous left
coronary artery to the ascending aorta was performed. Un-
fortunately, weaning from the extracorporeal circulation
was impossible as a result of low cardiac output syndrome,
leading to implantation of an ECMO device. Because of im-
paired left ventricular function, weaning from ECMO failedFrom the Department of Thoracic and Cardiovascular Surgery, University Hospital
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The Journal of Thoracic and Cawithin the next 3 weeks. We therefore decided to switch to
a BerlinHeart EXCOR VAD system and listed the patient
for cardiac transplant.
At the time of implantation, the infant weighed 5000 g and
had a body length of 55 cm. Accordingly, a 10-mL blood
pump was chosen.
The implantation of the apex cannula, which was 6 mm in
diameter, was performed as usual with 10 U-formed stitches
of 5-0 polypropylene (Prolene; Ethicon, Inc, Somerville,
NJ). An arterial cannula with a diameter of 6 mm was chosen
as the outflow graft; however, the ascending aorta had a di-
ameter smaller than 5 mm. In addition, the suture ring of the
arterial cannula had a diameter of 16 mm (Figure 1, A). To
adjust this difference between aortic and cannula diameters,
we use a simple method.
First, the suture ring was jacketed with an oval, formed
bovine pericardium with a center hole diameter of 9 mm
(outer diameter of the arterial cannula). This was adjusted
to the tip of the cannula and sewn below the cannula ring.
Four U-formed stitches with 5-0 Prolene were put through
the pericardium and cannula ring (Figure 1, B). The outer
border of the pericardium was sutured around the suture
ring with a 5-0 Prolene continuous suture (Figure 1, C).
The 4 U-formed 4-0 Prolene sutures that had been put
through the pericardium and cannula ring were then pulled
and knotted. After tangential clamping of the ascending
aorta, a 6-mm longitudinal incision was performed. The
more flexible pericardium border could easily be sutured
subsequently with the aortic incision wall with a 5-0 Prolene
continuous suture (Figure 2).
With this technique, it is easy to make intraoperative ad-
justments to correct any size mismatch between the suture
ring and the ascending aorta.
The infant has been growing normally since the procedure
(current weight 8 kg, current height 90 cm). He has had the
device for 1 year now and is awaiting cardiac transplant.DISCUSSION
A major problem of infants awaiting transplants is their
high mortality. According to the United Network for Organ
Sharing, of the more than 1600 infants added to the heart or
heart–lung transplant lists during the last decade, fewer than
50% received donor organs.2
In addition, assist devices are of significant importance in
the growing field of end-stage heart failure in the pediatricrdiovascular Surgery c Volume 139, Number 3 783
FIGURE 1. Normal EXCOR arterial cannula (A), after jacketing with bovine pericardium (B), and after suturing of outer border with EXCOR suture
ring (C).
FIGURE 2. Suturing of EXCOR cannula with bovine pericardium to small
ascending aorta (A) and final implantation (B).
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plant.
Unfortunately, availability of assist devices for pediatric
use and especially for neonates is limited. Recognizing
this caveat, in 2005 the National Heart, Lung, and Blood In-
stitute solicited proposals for the development of novel cir-
culatory support systems for pediatric patients with
congenital or acquired cardiovascular disease.3 Before full
Food and Drug Administration approval, some devices can
only be used in a compassionate use situation under investi-
gational device exemption. The BerlinHeart EXCOR Pediat-
ric VAD system has had such investigational device
exemption since October 2008.
Especially in neonates, implantation of the arterial can-
nula into a small ascending aorta can be difficult because
of the large and rigid suture ring. The technique described
here is a feasible and practical option for this situation. It
could be chosen intraoperatively, in particular if the center
does not have enough pediatric cannulas in stock.References
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